LFB SA Board of Directors
Composition of the LFB SA Board of Directors, chaired by Denis DELVAL, chairman and CEO of LFB SA.
French government representative:
Jérémie GUE
Head of the Legal Division at the Government Investments Agency (APE)
Members of the Board appointed by the General Assembly, proposed by French State:
Pascale AUGÉ
Chair of the Executive Board, INSERM TRANSFERT SA
François AUVIGNE
Inspector of Taxes, IFG, Ministry of Action and Public Accounts
Denis DELVAL
CEO of LFB
Corinne FAU
Member of the Board and Director of Finance, Purchasing and Insurance for ENEDIS
Laurence MÉGARD
Deputy Director in sectors of Health, Fashion and Luxury Industries and Consumer Goods, DGE
Independent members of the Board appointed by the General Assembly:
Gilles BRISSON
Member of the Supervisory Board of Innate Pharma (SA) and of the Supervisory Board of Financière Verdi III (SAS)
Eric DRAPÉ
Executive VP TEVA PHARMACEUTICALS Ltd , Member of the Board Teva Takeda Pharma Ltd (Japan, SAS)
Members of the Board representing employees:
Dominique SAINT PICQ
Change Control Coordinator – LFB BIOMEDICAMENTS
Jérôme WACRENIER
IT industrial engineer – Arras plant - LFB BIOMEDICAMENTS
Financial and Economic auditors:
François GUILLON
Auditing PRICEWATERHOUSECOOPERS firm
Laurent BRUN
Cabinet CAILLIAU DEDOUIT and associated
Guests
Maurice-Pierre PLANEL
Government auditor, Général Deputy Director of Health
Marc GAZAVE
Economic and Financial Controller